Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kammen

Showing results (531-540 of 549) with videos related to

Pageof 55
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|June 6, 2023
Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countriesAnita van de Munckhof, Afshin Borhani-Haghighi, Sanjith Aaron, et al.
Frontiers in Neurology|October 2, 2023
Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
European Journal of Neurology|May 11, 2023
A scoring tool to predict mortality and dependency after cerebral venous thrombosisErik Lindgren, Katarzyna Krzywicka, Maria A de Winter, et al.
Frontiers in Neurology|October 8, 2024
Corrigendum: Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
Blood Advances|December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.
Nature Communications|October 15, 2020
Near-real-time monitoring of global CO<sub>2</sub> emissions reveals the effects of the COVID-19 pandemicZhu Liu, Philippe Ciais, Zhu Deng, et al.
Nature Communications|December 3, 2020
Author Correction: Near-real-time monitoring of global CO<sub>2</sub> emissions reveals the effects of the COVID-19 pandemicZhu Liu, Philippe Ciais, Zhu Deng, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 13, 2024
External validation of the SI<sub>2</sub>NCAL<sub>2</sub>C score for outcomes following cerebral venous thrombosisPiers Klein, Liqi Shu, Erik Lindgren, et al.
Journal of Stroke|October 9, 2019
External Validation of the ELAPSS Score for Prediction of Unruptured Intracranial Aneurysm Growth RiskMayte Sánchez van Kammen, Jacoba P Greving, Satoshi Kuroda, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2012
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Adam L Boxer, Michael Gold, Edward Huey, et al.
Pageof 55

Showing results (531-540 of 549) with videos related to

Sort By:
Pageof 55
International Journal of Stroke : Official Journal of the International Stroke Society|June 6, 2023
Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countriesAnita van de Munckhof, Afshin Borhani-Haghighi, Sanjith Aaron, et al.
Frontiers in Neurology|October 2, 2023
Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
European Journal of Neurology|May 11, 2023
A scoring tool to predict mortality and dependency after cerebral venous thrombosisErik Lindgren, Katarzyna Krzywicka, Maria A de Winter, et al.
Frontiers in Neurology|October 8, 2024
Corrigendum: Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
Blood Advances|December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.
Nature Communications|October 15, 2020
Near-real-time monitoring of global CO<sub>2</sub> emissions reveals the effects of the COVID-19 pandemicZhu Liu, Philippe Ciais, Zhu Deng, et al.
Nature Communications|December 3, 2020
Author Correction: Near-real-time monitoring of global CO<sub>2</sub> emissions reveals the effects of the COVID-19 pandemicZhu Liu, Philippe Ciais, Zhu Deng, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 13, 2024
External validation of the SI<sub>2</sub>NCAL<sub>2</sub>C score for outcomes following cerebral venous thrombosisPiers Klein, Liqi Shu, Erik Lindgren, et al.
Journal of Stroke|October 9, 2019
External Validation of the ELAPSS Score for Prediction of Unruptured Intracranial Aneurysm Growth RiskMayte Sánchez van Kammen, Jacoba P Greving, Satoshi Kuroda, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2012
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Adam L Boxer, Michael Gold, Edward Huey, et al.
Pageof 55